Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Comput Stat Data Anal. 2012 Apr 9;56(12):4312–4319. doi: 10.1016/j.csda.2012.04.001

Induced Smoothing for the Semiparametric Accelerated Hazards Model

Haifen Li a,b, Jiajia Zhang b,*, Yincai Tang a
PMCID: PMC3462890  NIHMSID: NIHMS369505  PMID: 23049151

Abstract

Compared to the proportional hazards model and accelerated failure time model, the accelerated hazards model has a unique property in its application, in that it can allow gradual effects of the treatment. However, its application is still very limited, partly due to the complexity of existing semiparametric estimation methods. We propose a new semiparametric estimation method based on the induced smoothing and rank type estimates. The parameter estimates and their variances can be easily obtained from the smoothed estimating equation; thus it is easy to use in practice. Our numerical study shows that the new method is more efficient than the existing methods with respect to its variance estimation and coverage probability. The proposed method is employed to reanalyze a data set from a brain tumor treatment study.

Keywords: Accelerated Hazards Model, Rank Estimation, Induced Smoothing

1. Introduction

The proportional hazards (PH) model (Cox, 1972) and accelerated failure time (AFT) model (Cox and Oakes, 1984) are the most popular survival models in practice. Unlike the PH model and AFT model, there is little discussion of the accelerated hazards (AH) model (Chen and Wang, 2000) in the literature, partly due to its complex estimation methods.

Let us denote h(·) as the hazard risk, t as the event time and x as the possible covariate vector. The AH model can be written as

h(tx)=h0(teβx), (1)

where h0(·) is an arbitrary unknown baseline hazard function and β is a vector of unknown parameters of interest. When t = 0, h(0|x) = h0(0), so the main characteristic of the AH model is that it allows the treatment effect to release gradually, and a lag period may exist before the treatment is fully effective (Zucker and Lakatos, 1990). It is worthwhile pointing out that neither the PH model nor the AFT model can allow the same hazard risk at time 0 because h(0|x) = h0(0)eβx in both models, which means both the PH model and the AFT model implicitly expect the treatment to take a significant effect immediately following its application (Zhang and Peng, 2009a). Furthermore, another difference among the PH, AFT and AH models is the crossing status of the hazard function. As mentioned in Zhang and Peng (2009b), the hazard function from the AFT model and AH model may have crossing point which is not allowed in the PH model.

A typical application of the AH model is to evaluate the effectiveness of biodegradable carmustine (BCNU) polymers to the recurrent brain malignant gliomas (Brem et al., 1995). In order to reach a higher local drug concentration, the BCNU polymer was supposed to gradually release BCNU in the first 3-week period following placement. The kernel smoothed hazard curve with 8-week bandwidth based on the Nelson-Aalen estimation method for each group is investigated in Figure 1, which clearly displays the pattern of hazard risk between the placebo and BCNU treatment group. The BCNU treatment does not have any effects during the first three weeks. It has a tendency to increase the hazard risk between 3–40 weeks, and decrease thereafter. Furthermore, the hazard curves of the placebo and BCNU treatment have two crossing points around the 31st and 42nd weeks. That is, the BCNU group has lower risk between 3–32 and after 43 weeks, while it has higher risk between 33–43 weeks. The gradual effects and crossing points provide evidence to apply the AH model to this data set. More discussions can be found in Chen (2001), Chen and Wang (2000) and Zhang et al. (2011).

Figure 1.

Figure 1

Fitted Kernel-Smoothed Hazard Functions for the Placebo and BCNU Trial

The computational challenges in estimating both regression parameters and the covariance matrix of the AH model may limit its application in practice. Chen and Wang (2000) proposed a semiparametric estimation method based on a rank-type estimation method. The variance of an estimated parameter will depend on the nonparametric estimator of the baseline hazard function and its numerical derivative and the parameter estimates must be obtained through a root finding procedure, which may increase computational difficulties in practice. Chen (2001) improved the variance estimation procedure and Chen and Jewell (2001) extended the estimation method to a more general model. Zhang et al. (2011) proposed an efficient semiparametric estimation method in the AH model based on a kernel-smoothed approximation of the profile likelihood function. The covariance matrix can be consistently estimated by the second derivative of the approximation of the profile likelihood function. However, as they illustrated, the estimated variances from the Hessian matrix of the kernel-smoothed profile likelihood approximation may underestimate the true variances when the sample size is small, or even moderate.

The purpose of this paper is to address the nonsmoothed rank type estimating equation by the induced smoothing approach, which is an advanced technique used in the AFT model (Brown and Wang, 2007), the clustered AFT model (Johnson and Strawderman, 2009; Fu et al., 2010), and the quantile regression model (Pang et al., 2010). We successfully develop an estimation method for the regression parameters and variance estimation for the AH model based on the induced smoothing technique. The rest of this article is organized as follows. In Section 2, we describe the induced smoothing method for the AH model based on the rank-type estimating equation and establish its asymptotic properties. Simulation studies are conducted in Section 3 to investigate the finite-sample behavior of the proposed method. We revisit the brain malignant gliomas example in Section 4 and make conclusions in Section 5.

2. Estimation method

Let Oi = (ti, δi, xi) denote the observed data for the ith individual, i = 1, …, n, where ti is the observed survival time, δi is the censoring indicator with δi = 1 for an uncensored ti and δi = 0 for a censored ti, and xi is the corresponding p × 1 covariate vector. We assume that censoring is independent and noninformative.

2.1. Rank type estimation method

Chen and Wang (2000) proposed to estimate β using a weighted rank-type estimating equation, which can be written as

Unw(β)=i=1nwi(β)δi(xij=1nI(rj(β)ri(β))eβxjxjj=1nI(rj(β)ri(β))eβxj)=0, (2)

where ri(β) = log ti + βxi, i = 1, …, n and wi(·) are nonnegative weight functions. Assuming wig(·) is the Gehan type weight function, which is wig(β)=1nj=1nI(rj(β)ri(β))eβxj, the Gehan-rank estimating equation is

Ung(β)=1ni=1nj=1nδi(xixj)I(rj(β)ri(β))eβxj=0. (3)

Estimation of regression parameters can be obtained by solving equation (2) or (3) with respect to β. As mentioned in Chen et al. (2002), the estimated β asymptotically follows a normal distribution with mean 0 and variance Ψ, where Ψ=Dn1BnDn1,Bn=Var{Unw(β)}, and Dn=[E{Unw(β)}/β]β0. Bn can be approximated by

B^n=i=1n[wi(β)δi(xij=1nI(rj(β)ri(β))eβxjxjj=1nI(rj(β)ri(β))eβxj)]2

where v⊗2 = vv′ for any vector v. But, the approximation of Dn is a challenging task since the closed form of partial derivatives of E{Unw(β)} does not exist.

Therefore, Chen (2001) presented an alternative method to estimate the variance. He first decomposed the empirical estimate n as σσ′, where σ = (σ1, …, σp)′, and computed the solutions of Unw(bi)=σi, for i = 1, …, p. The variance estimator of n1/2(β̂β0) is then given by (b1β̂1, …, bpβ̂p)(b1β̂1, …, bpβ̂p)′. This algorithm is applied in our simulations for the rank-type method.

2.2. Induced smoothing method

Based on the similar idea of Brown and Wang (2005), we consider the smoothed estimating function Ũn(β, Σ), which is constructed by adding the random perturbation (Σ/n)1/2Z to β in the score function Ung(β) and then taking the expectation of the nonsmoothed estimating function with respect to Z, where Z is a N(0, Ip) random vector independent of the data (Ip is the p × p identity matrix), and Σ = O(1) is some symmetric positive definite matrix. Let uij=1n(xixj)(xixj),vij=1nxj(xixj),uj=1nxjxj, the smoothed version of Ung(β,) is

Un(β,)=EZ{Ung(β+(/n)1/2Z)}=1ni=1nj=1nδi(xixj)euj2βxjΦ(rj(β)ri(β)uij+vijuij), (4)

where Φ(·) be the cumulative distribution function of the standard normal distribution. The above smoothed estimating equation is a monotone decreasing function with respect to each element of β. Appendix gives more detail for deriving Ũn(β, Σ) and its monotonicity. When Σ is given, the smoothed regression coefficient estimator β̃ can be obtained by solving the equation Ũn(β, Σ) = 0. When Σ is unknown, we can get its estimate by iterating the estimating equation, which uses a symmetric positive definite p × p matrix Σ̃0 = O(1) as its initial value. In fact, as long as the matrix used for the initial smoothing is positive definite with order O(1), the corresponding smoothed coefficient estimator β̃ is asymptotically equivalent to β̂.

According to Brown and Wang (2007), the estimation of the asymptotic variance is mainly based on the sandwich form of the covariance matrix of estimated parameters. The partial derivatives of the smoothed estimating function (4) can be explicitly expressed as

Dn(β,)=Un(β,)β=1ni=1nj=1nδi(xixj)euj/2βxj[φ(dij)(xixj)uij+Φ(dij)xj],

where dij=rj(β)ri(β)uij+vijuij, φ(·) is the probability density function of the standard normal distribution, which is negative when d and x are bounded. Then, its variance can be similarly developed as

B^n(β,)=1n2i=1n[δij=1n(xixj)euj/2βxjΦ(dij)]2,

Thus, the asymptotic variance of the estimated parameter can be consistently estimated via Dn1B^nDn1.

As suggested in Pang et al. (2010), an iterative procedure can be used to simultaneously estimate the regression parameters and their covariance matrix. The estimation procedure consists of the following steps:

  • Step 1

    Let β̃0 = β̂, the estimator solved from the Gehan weighted rank-type estimating equation (3), and Σ̃0 = Ip.

  • Step 2
    Given β̃k−1 and Σ̃k−1 from the (k − 1)th step, update β̃k and Σ̃k as:
    βk=βk1+{Dn(βk1,k1)}1Un(βk1,k1),andk=Dn1(βk,k1)B^n(βk,k1)Dn1(βk,k1),
  • Step 3

    Repeat until a selected stopping criterion, max(max |β̃kβ̃k−1|, max |Σ̃kΣ̃k−1|) < τ0, is reached. The convergence is controlled by τ0 = 10−4 in the simulation and real data analysis.

Denote the coefficient estimates and their associated covariance estimate at convergence as β̃ and Σ̃, respectively. When β̃ is available, the Breslow-type estimator of the baseline cumulative hazard function (Chen et al., 2002) is

H^0(t,β)=i=1nδiI(log(t)ri(β))j=1nI(rj(β)ri(β))eβxj

Based on Ĥ0(t, β̃), we can obtain the smoothed hazard curve by the kernel smoothing method. For an arbitrary time point t, which satisfies bt ≤ max(ti) − b, similar to Klein and Moeschberger (2003), the kernel-smoothed hazard estimator of Ĥ0(t) is

H^0(t)=b1i=1nK(ttib)ΔH^0(ti,β)

where K(·) is the kernel function and b denotes the bandwidth. The choice of the kernel function can be found in Klein and Moeschberger (2003), and we use the Epanechnikov kernel, which is K(x) = 0.75(1 − x2) for −1 ≤ x ≤ 1, in the real data analysis.

3. Simulation study

We conduct simulation studies to investigate the performance of the proposed estimation method. We generate the data from the AH model (1) with x = (x1, x2), where x1 is generated from the standard normal distribution, and x2 is generated from the binary distribution with the probability of 0.5. The regression coefficient β = (β1, β2)′ is set to (1, −1)′. The baseline hazard function h0(t) comes from the log-normal distribution (LN(0,1)), log-logistic distribution with shape parameter 2 and scale parameter 1, and weibull distribution with both the shape and scale parameters equal to 0.5. The censoring times are generated independently from the uniform distribution U(0, a) with proper values of a so that the resulting censoring rates are about 15% and 30%. The sample sizes are 500 and 1000, with 1000 simulation replications.

We fit the data with the AH model using the induced smoothing method. For comparison purposes, we also list results from the Gehan rank-type method (Chen and Wang, 2000) and profile likelihood method (Zhang et al., 2011). The Gehan rank-type method is described in Section 2.1. The profile likelihood method (Zhang et al., 2011) is based on a kernel-smoothed approximation of the limit of the profile likelihood function, which is

l(β)=1ni=1nδi{ri(β)+log[1nanj=1nδjK(rj(β)ri(β)an)1nj=1nrj(β)ri(β)aneβxjK(s)ds]} (5)

where ri(β) = log ti + βxi, K(·) is the kernel function and an is the bandwidth. The estimation of β can be obtained through maximizing (5). Similar to Zhang et al. (2011), we choose the kernel function K(·) to be the standard normal density function and the bandwidth to be the optimal bandwidths for convenience, which are (82/3)1/5σ1n1/5 for the kernel density and 41/3σ2n−1/3 for the cumulative kernel density, where σ1 and σ2 are the sample standard deviations of ri(β) using uncensored individuals and all individuals, respectively, based on the initial value of β.

The biases (Bias), empirical standard deviations (StDev), average of the standard error estimates (StErr), and coverage probability (CP) of β1 and β2 are computed and summarized in Table 1.

Table 1.

Simulation Results for 1000 Replications

cen. n β̂ Induced Smoothing Profile Likelihood Gehan Rank-type

Bias StDev StErr CP Bias StDev StErr CP Bias StDev StErr CP
Log-normal baseline distribution
15% 500 β̂1 −0.013 0.112 0.112 0.924 0.039 0.117 0.109 0.915 −0.013 0.113 0.088 0.852
β̂2 0.009 0.228 0.225 0.934 −0.037 0.208 0.202 0.945 0.009 0.226 0.205 0.915
1000 β̂1 −0.003 0.076 0.079 0.942 0.023 0.077 0.074 0.926 −0.003 0.076 0.065 0.897
β̂2 −0.001 0.161 0.158 0.942 −0.022 0.145 0.139 0.944 0.000 0.160 0.145 0.917

30% 500 β̂1 0.000 0.125 0.118 0.917 0.050 0.131 0.119 0.907 0.000 0.125 0.090 0.834
β̂2 −0.007 0.226 0.227 0.942 −0.054 0.233 0.214 0.929 −0.007 0.225 0.201 0.912
1000 β̂1 −0.005 0.083 0.083 0.933 0.027 0.084 0.080 0.920 −0.005 0.083 0.066 0.879
β̂2 0.002 0.159 0.162 0.948 −0.016 0.160 0.145 0.915 0.003 0.159 0.144 0.919

Log-logistic baseline distribution
15% 500 β̂1 −0.008 0.104 0.107 0.936 0.071 0.118 0.105 0.880 −0.009 0.104 0.079 0.846
β̂2 0.004 0.193 0.192 0.939 −0.073 0.197 0.184 0.918 0.006 0.191 0.167 0.907
1000 β̂1 0.000 0.070 0.075 0.952 0.041 0.074 0.071 0.916 0.000 0.070 0.058 0.891
β̂2 −0.003 0.136 0.135 0.938 −0.040 0.121 0.123 0.953 −0.003 0.136 0.116 0.905

30% 500 β̂1 0.006 0.123 0.119 0.935 0.094 0.177 0.122 0.857 0.006 0.122 0.085 0.829
β̂2 −0.013 0.203 0.205 0.948 −0.099 0.244 0.206 0.917 −0.012 0.201 0.171 0.907
1000 β̂1 −0.002 0.081 0.082 0.945 0.043 0.086 0.079 0.907 −0.002 0.081 0.062 0.867
β̂2 0.000 0.140 0.143 0.951 −0.042 0.142 0.134 0.923 0.000 0.140 0.120 0.897

Weibull baseline distribution
15% 500 β̂1 0.027 0.164 0.163 0.945 −0.079 0.108 0.113 0.879 0.028 0.165 0.161 0.944
β̂2 −0.021 0.275 0.272 0.944 0.093 0.182 0.192 0.936 −0.021 0.273 0.239 0.911
1000 β̂1 0.013 0.109 0.112 0.957 −0.047 0.080 0.082 0.896 0.013 0.110 0.105 0.941
β̂2 −0.006 0.191 0.188 0.942 0.054 0.141 0.139 0.929 −0.006 0.190 0.163 0.906

30% 500 β̂1 0.013 0.165 0.166 0.948 −0.056 0.121 0.120 0.911 0.015 0.172 0.165 0.947
β̂2 0.004 0.274 0.278 0.951 0.071 0.200 0.205 0.942 0.004 0.275 0.246 0.917
1000 β̂1 0.008 0.111 0.114 0.958 −0.028 0.087 0.087 0.936 0.008 0.111 0.108 0.956
β̂2 −0.006 0.196 0.194 0.947 0.037 0.145 0.149 0.950 −0.007 0.198 0.171 0.913

From Table 1, the performance of all methods are quite similar for the different distributions. With respect to the bias, the proposed method and Gehan rank-type method are similar, which are smaller than that from the profile likelihood method; while these three methods are comparable with respect to the StDev. For the induced smoothing method, the standard error estimates (StErr) are close to the empirical standard deviations (StDev), which shows that the proposed variance estimation method performs well in the simulation settings, and the coverage probability is close to its nominal level (95%). Compared to the profile likelihood method, the proposed method is more reliable with respect to its bias, variance and CP. The StDev is closer to StErr for the proposed approach than for the profile likelihood method, and the CP is closer to its nominal level. Compared to the Gehan rank-type method, the bias and StDev for the proposed method are almost the same, while the StErr and CP are significantly improved. For example, under the log-normal baseline distribution with 15% censoring, β1 = −0.003, 0.076, 0.079, 0.942 when n = 1000 from the induced smoothing method, 0.023, 0.077, 0.074, 0.926 from the profile likelihood method, and −0.003, 0.076, 0.065, 0.897 from the Gehan rank-type method. When the sample size increases, the bias or variance of the estimated parameters will decrease. With an increase in the censoring rate, the bias or variance of the estimated parameters will increase.

From our computation experience, the iterative procedure will converge in 5 iterations for 99% of data sets. However, one must be cautious with small sample size (< 200) due to the possible convergence issue. We ran the simulations using 8 parallel 2300 MHZ cpu of a Quad-Core AMD opteron processor. When the sample size is 500, the total computing time for completing 1000 simulation replications is about 7.8 hours for the proposed method, 2.7 hours for the profile likelihood method, and 11.6 hours for the Gehan rank-type method. The proposed method is not as fast as the profile likelihood method, but it is acceptable considering its overall performance.

4. Brain tumor treatment

The proposed method will be used to evaluate the effectiveness of BCNU polymers. In this trial, 110 of 222 participants were randomized to the BCNU polymer treatment group, and 112 were randomized to the placebo polymer control group. In analyzing the BCNU trial, we are interested in estimating the treatment effect in the early period. Therefore, similar to Chen and Wang (2000), we conducted separate analyses for the first 26-week period, which has 53.6% censoring, and for the first 52-week period, which has 20.7% censoring. The results are summarized in Table 2.

Table 2.

Results for Analysis of the BCNU trial

Induced Smoothing Profile Likelihood Gehan Rank-type
First 26 weeks β̂ −0.5883 −0.4243 −0.5889
Var(β̂) 0.0378 0.0118 0.0257
95% CI (−0.9693, −0.2074) (−0.6371, −0.2114) (−0.9033, −0.2947)

First 52 weeks β̂ −0.6054 −0.4785 −0.6086
Var(β̂) 0.0314 0.0259 0.0601
95% CI (−0.9527, −0.3030) (−0.7937, −0.1632) (−1.0892, −0.1697)

The results are consistent with the results reported in Chen and Wang (2000). From Table 2, we can see that the BCNU is significant in both periods. The BCNU extends the time scale of hazard risk. This means to reach the same level of risk, the patients in the BCNU will need e0.5883 = 1.80 times of the time of the placebo group in the first 26 weeks and e0.6054 = 1.83 times of the time needed by the placebo group in the first 52 weeks. For comparison purposes, we plot the fitted kernel smoothed hazard function along with the kernel smoothed hazard function based on the Nelson-Aalen estimates in Figure 2, where both of them use the bandwidth=8 weeks. This displays the good performance of this method, since the fitted curves are close to the ones from the nonparametric approach. From Figure 2(a), we can see that the hazard in the BCNU group is smaller than that in the placebo group in the first 26 weeks. In Figure 2(b), we can see the increasing and decreasing trend of hazard in the BCNU group in the first 52 weeks. Furthermore, the same starting point of the hazard function in each group clearly indicates the gradual effects of BCNU, which can only be captured by the AH model.

Figure 2.

Figure 2

Fitted Kernel-Smoothed Hazard Functions for Placebo and BCNU Trial

In order to reveal the effects of BCNU to the recurrent brain malignant gliomas, we also plot the estimated survival curves along with the one from the Kaplan Meier estimator in Figure 3. The closeness of the survival curves from both methods demonstrates good performances of the proposed method, and also shows that the BCNU can delay the recurrence of brain malignant gliomas.

Figure 3.

Figure 3

Fitted Survival Functions for Placebo and BCNU Trial

5. Discussions

In this paper, we propose a new semiparametric estimation method of the AH model, which is based on the induced smoothing technique and Gehan rank-type estimation. From simulation studies, we show that the proposed method is more efficient compared to existing methods with regard to its parameter estimates and variance estimation. The sandwich estimation method avoids the extra computational burden of the bootstrap method. From computation experience, the proposed method always converges with moderate sample size. It is worthwhile expanding the proposed method to more general cases such as the multivariate case and the general class model (Chen and Jewell, 2001) in the future work.

Appendix

Deriving of Ũn(β, Σ)

We assume Z is a N(0, Ip) random vector independent of the data (Ip is the p × p identity matrix), and Σ = O(1) is some symmetric positive definite matrix.

Un(β,)=EZ{Ung(β+(/n)1/2Z)}=1ni=1nj=1nδi(xixj)EZ{I(rj(β+(/n)1/2Z)ri(β+(/n)1/2Z))e(β+(/n)1/2Z)xj}=1ni=1nj=1nδi(xixj)eβxjEZ{I((xixj)(/n)1/2Zrj(β)ri(β))exj(/n)1/2Z}. (6)

Let a=xj(/n)1/2 and b = (xixj )′ (Σ/n)1/2. We define new random variables Y1=aaaZ and Y2=bbbZ, which satisfy

(Y1Y2)N2((00),(1ρρ1)),

where ρ=abaabb. According to the character of binary normal distribution, random variables W1=Y1ρY21ρ2 and W2 = Y2 are independent and follow the standard normal distribution. Then, the expectation part of (6) can be rewritten as

E(W1,W2){I(W2rj(β)ri(β)bb)eaa(1ρ2W1+ρW2)}=EW1{eaa1ρ2W1}EW2{I(W2rj(β)ri(β)bb)eaaρW2}=eaa2Φ(rj(β)ri(β)bb+aaρ). (7)

where Φ(·) is the cumulative density function of the standard normal distribution. Let uij=1n(xixj)(xixj),vij=1nxj(xixj),uj=1nxjxj, we can obtain (4) by substituting (7) into the expectation part of (6).

Monotonicity of Ũn(β, Σ)

When Σis given, we will prove Ũn(β, Σ) is a monotone decreasing function when d and x are bounded, by showing its partial derivative with respect to βi, i = 1, …, p, β = (β1, …, βp), is non-positive. We will show the detail proof for one dimension, which can be extended to the p-dimension case.

First φ(d)/Φ(d) is a monotone decreasing function since the first derivative of φ(d)/Φ(d) is less than 0. Thus, for any ε = o(n−1/2) > 0, there exists |d| ≤ M, which satisfies φ(d)/Φ(d) ≥ ε. Assuming that |x| is bounded by (ε/σ)n, where ε/σ = o(n−1/2), the derivative of Ũn(β, σ) can be explicitly expressed by

Dn(β,σ)=1ni=1nj=1nδi(xixj)euj/2βxj[φ(dij)xixj(σ2/n)(xixj)2+Φ(dij)xj]i(xixj)xj<0δixixjeuj/2βxj[Φ(dij)xjφ(dij)1σ2/n]=i(xixj)xj<0δixixjeuj/2βxjΦ(dij)[xjφ(dij)Φ(dij)nσ]i(xixj)xj<0δixixjeuj/2βxjΦ(dij)[xj(ε/σ)n]0.

Therefore, the estimating equation Ũn(β, σ) is a monotone decreasing function when d and x are bounded.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Brem H, Piantadosi S, Burger P, Walker M, Selker R, Vick N, Black K, Sisti M, Brem S, Mohr G, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet. 1995;345(8956):1008–1012. doi: 10.1016/s0140-6736(95)90755-6. [DOI] [PubMed] [Google Scholar]
  2. Brown B, Wang Y. Standard errors and covariance matrices for smoothed rank estimators. Biometrika. 2005;92(1):149–158. [Google Scholar]
  3. Brown B, Wang Y. Induced smoothing for rank regression with censored survival times. Statistics in Medicine. 2007;26(4):828–836. doi: 10.1002/sim.2576. [DOI] [PubMed] [Google Scholar]
  4. Chen Y. Accelerated hazards regression model and its adequacy for censored survival data. Biometrics. 2001;57(3):853–860. doi: 10.1111/j.0006-341x.2001.00853.x. [DOI] [PubMed] [Google Scholar]
  5. Chen Y, Jewell N. On a general class of semiparametric hazards regression models. Biometrika. 2001;88(3):687–702. [Google Scholar]
  6. Chen Y, Jewell N, Yang J. Accelerated hazards model: Method, theory and applications. UC Berkeley Division of Biostatistics Working Paper Series. 2002:117. [Google Scholar]
  7. Chen Y, Wang M. Analysis of accelerated hazards models. Journal of the American Statistical Association. 2000;95(450):608–618. [Google Scholar]
  8. Cox D. Regression models and life-tables. Journal of the Royal Statistical Society Series B (Methodological) 1972;34(2):187–220. [Google Scholar]
  9. Cox D, Oakes D. Analysis of survival data. Chapman & Hall; 1984. [Google Scholar]
  10. Fu L, Wang Y, Bai Z. Rank regression for analysis of clustered data: A natural induced smoothing approach. Computational Statistics & Data Analysis. 2010;54(4):1036–1050. [Google Scholar]
  11. Johnson L, Strawderman R. Induced smoothing for the semiparametric accelerated failure time model: asymptotics and extensions to clustered data. Biometrika. 2009;96(3):577–590. doi: 10.1093/biomet/asp025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Klein J, Moeschberger M. Survival analysis: techniques for censored and truncated data. Springer Verlag; 2003. [Google Scholar]
  13. Pang L, Lu W, Wang H. Variance estimation in censored quantile regression via induced smoothing. Computational Statistics & Data Analysis. 2012;56:785–796. doi: 10.1016/j.csda.2010.10.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Zhang J, Peng Y. Accelerated hazards mixture cure model. Lifetime Data Analysis. 2009a;15(4):455–467. doi: 10.1007/s10985-009-9126-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zhang J, Peng Y. Crossing hazard functions in common survival models. Statistics & Probability Letters. 2009b;79(20):2124–2130. doi: 10.1016/j.spl.2009.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Zhang J, Peng Y, Zhao O. A new semiparametric estimation method for accelerated hazard model. Biometrics. 2011;67(4):1352–1360. doi: 10.1111/j.1541-0420.2011.01592.x. [DOI] [PubMed] [Google Scholar]
  17. Zucker D, Lakatos E. Weighted log rank type statistics for comparing survival curves when there is a time lag in the effectiveness of treatment. Biometrika. 1990;77(4):853–864. [Google Scholar]

RESOURCES